Alembic Pharmaceuticals has informed that the NCD Committee of the company at its meeting held today has allotted 1,500, 8.37% Unsecured Listed Rated Redeemable Non-Convertible Debentures (NCDs) of Rs 10,00,000 per NCD aggregating to Rs 150,00,00,000 under Tranche III. The detailed disclosure pursuant to Regulation 30(2) of Listing Regulations, 2015 for Tranche is enclosed herewith as Annexure - 1.The time of commencement of the NCD Committee Meeting was 10:00 am and the time of conclusion was 10:30 am.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: